1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Argentina Pharmaceuticals and Healthcare Report Q3 2015

Argentina Pharmaceuticals and Healthcare Report Q3 2015

  • May 2015
  • -
  • Business Monitor International
  • -
  • 137 pages

Includes 3 FREE quarterly updates

BMI View:
Argentina's pharmaceuticals and healthcare sector is expected to experience improved growthrates through the next decade, standing slightly behind growth patterns in the other large markets in LatinAmerica. Combined with expected improvements in the Argentinean business environment to take placewith the next government administration since 2016, risks to our pharmaceuticals and healthcare forecastsare weighted to the upside. However, we expect a more mixed market growth picture through the rest of2015, with expansionary fiscal policy ahead of general elections not able to offset modest consumerconfidence. More broadly, lax intellectual property protection will continue to hinder the pharmaceuticalmarket potential while deterring more significant levels of foreign investment.
Headline Expenditure Projections
Pharmaceuticals: ARS49.89bn (USD6.09bn) in 2014 to ARS54.63bn (USD5.67bn) in 2015; +7.3% inlocal currency terms and -6.9% in US dollar terms. Forecast broadly in line with the previous quarter.Healthcare: ARS278.35bn (USD33.94bn) in 2014 to ARS304.07bn (USD32.18bn) in 2015; +9.2% in localcurrency terms and -5.2% in US dollar terms. Forecast broadly in line with the previous quarter.

Table Of Contents

Argentina Pharmaceuticals and Healthcare Report Q3 2015
BMI Industry View ...... 7
SWOT ............ 9
Political .......... 11
Economic ........ 12
Operational Risk ............. 13
Industry Forecast ..... 15
Pharmaceutical Market Forecast ....... 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Argentina 2011-2019) . . . . 17
Healthcare Market Forecast ............. 18
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2011-2019) . . . . . 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2011-2019) . . . 20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2011-2019) . . . 20
Prescription Drug Market Forecast ... 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Argentina 2011-2019) . . . . . 22
Patented Drug Market Forecast ........ 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Argentina 2011-2019) . . . 25
Generic Drug Market Forecast ......... 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Argentina 2011-2019) . . . . 28
OTC Medicine Market Forecast ........ 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Argentina 2011-2019) . . . . . 31
Pharmaceutical Trade Forecast ........ 31
Table: Pharmaceutical Trade Data And Forecasts (Argentina 2013-2019) . . . 33
Table: Pharmaceutical Trade Data And Forecasts local currency (Argentina 2013-2019) . . . . . 34
Key Risks To BMI's Forecast Scenario 34
Macroeconomic Forecasts ..... 36
Economic Analysis ........... 36
Table: Economic Activity (Argentina 2010-2019) 41
Industry Risk Reward Ratings 42
Americas Risk/Reward Index ............ 42
Argentina Risk/Reward Index ............ 47
Rewards ........ 48
Risks ............. 48
Market Overview ...... 50
Industry Trends And Developments ..... 52
Epidemiology . 52
Healthcare ..... 53
Healthcare Insurance ...... 54
Medical Tourism ............ 56
Table: Health Status 57
Table: Healthcare Funding . . . . . 57
Table: Healthcare Resources (Argentina 2009-2014) . . 58
Table: Healthcare Personnel (Argentina 2009-2014) . . 58
Table: Healthcare Activity (Argentina 2009-2014) . . . . . 59
Research and Development 59
Table: Pharmaceutical RandD Investment, 2001-2007 . . 60
Clinical Trials 63
Regulatory Development ........ 65
Table: Product Registration, Annex I and II Listed Countries 66
Intellectual Property Environment .... 72
Pricing and Reimbursement 76
Table: Pharmaceutical Price Build-Up . . . . 77
Table: Taxes Paid By The Pharmaceutical Industry By Type, 2005-2007 (ARSmn) 78
Table: Drug Price Freeze, 2005-2008 . . . . . 79
Reimbursement Regime ... 79
Other Regulatory Issues .. 80
Competitive Landscape .......... 83
Research Based Industry . 84
Generic Drugmakers ...... 87
Recent Company Developments ....... 89
Pharmaceutical Wholesale Sector .... 92
Retail Pharmacy Sector ... 93
Company Profile ....... 97
Roemmers ....... 97
Laboratorios Bago ......... 101
Novartis ........ 105
Boehringer Ingelheim ..... 108
Merck and Co ... 111
GlaxoSmithKline ........... 114
Roche ........... 117
Sanofi ........... 120
Pfizer ........... 123
Demographic Forecast ......... 126
Table: Population Headline Indicators (Argentina 1990-2025) . . 127
Table: Key Population Ratios (Argentina 1990-2025) 127
Table: Urban/Rural Population and Life Expectancy (Argentina 1990-2025) . . 128
Table: Population By Age Group (Argentina 1990-2025) . . . 128
Table: Population By Age Group % (Argentina 1990-2025) 129
Glossary ... 131
Methodology ........... 133
Pharmaceutical Expenditure Forecast Model .. 133
Healthcare Expenditure Forecast Model ......... 133
Notes On Methodology .. 134
Risk/Reward Index Methodology .... 135
Index Overview ............ 136
Table: Pharmaceutical Risk/Reward Index Indicators 136
Indicator Weightings .... 137

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Drug Discovery Outsourcing Global Market  – Forecast To 2022

Drug Discovery Outsourcing Global Market – Forecast To 2022

  • $ 15 000
  • Industry report
  • January 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards ...

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

  • $ 6 995
  • Industry report
  • February 2016
  • by GBI Research

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes Summary The breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 ...

Global Markets for Infectious Disease Treatments

Global Markets for Infectious Disease Treatments

  • $ 6 650
  • Industry report
  • January 2016
  • by BCC Research

This BCC Research report provides the reader with a detailed analysis of the global infectious disease market, with emphasis on seven major infectious diseases (i.e., human immunodeficiency virus/acquired ...


Download Unlimited Documents from Trusted Public Sources

Global Anti-Infective Markets - Forecast

  • April 2016
    82 pages
  • Anti-Infective  

    Infectious Dise...  

  • World  

    Africa  

View report >

Pharmacies And Drug Stores Industry in the UK

  • April 2016
    3 pages
  • Pharmaceutical  

    Pharmaceutical  

  • United Kingdom  

View report >

Open Source Industry in the US

  • April 2016
    8 pages
  • Open Source  

    Drug Delivery T...  

  • United States  

    North America  

View report >

Pathology Description

19 days ago

Related Market Segments :

Pharmaceutical
Healthcare

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.